Hematologi Onkologi hematolog-onkologis Terbaik di Áustria - TOP-5 dokter

Profesor Drach adalah seorang spesialis dalam bidang onkologi dengan gelar PhD dari Universitas Kedokteran Wina. Ia memiliki pengalaman dalam penelitian, kedokteran internal, hematologi onkologi, nutrisi, dan gaya hidup pada kanker. Ia adalah Direktur Klinik Privat Josefstadt di Wina dan anggota Dewan Direksi Perhimpunan Hematologi dan Onkologi Austria. Ia telah menerbitkan lebih dari 120 makalah ilmiah dan memberikan lebih dari 200 kuliah/presentasi.

Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.

Dr. Hossein Taghizadeh is a highly regarded Austrian specialist in internal medicine, hematology, and medical oncology, known for his compassionate approach and commitment to personalized cancer care. With extensive experience in treating solid tumors and blood cancers, he represents a new generation of oncologists who integrate scientific progress with empathy and precision.

He studied medicine at the Medical University of Vienna, graduating in 2016, and began his residency in internal medicine and oncology shortly thereafter. His academic and clinical training at leading Austrian cancer centers equipped him with deep expertise in systemic cancer therapy, hematologic diseases, and palliative medicine.

2010–2016 – Studied medicine at the Medical University of Vienna.

2018 – Began residency in internal medicine and medical oncology, focusing on individualized treatment strategies.

2020s – Specialized in solid tumors, hematologic malignancies, and targeted therapy, contributing to multidisciplinary oncology care.

Today – Practices as an oncologist at Oncodoc and Wiener Privatklinik, providing diagnostics, systemic treatment, and follow-up for patients with gastrointestinal, urogenital, and hematologic cancers.

Dr. Taghizadeh’s clinical interests include gastrointestinal tumors, pancreatic and biliary cancers, genitourinary malignancies, and hematologic neoplasms. He works with advanced diagnostic tools and modern systemic therapies, including chemotherapy, targeted therapy, and immunotherapy.

Known for his calm professionalism, integrity, and patient-centered communication, Dr. Taghizadeh places great emphasis on evidence-based medicine and emotional support throughout the treatment journey. His work reflects a modern, holistic approach to oncology — one that values both medical excellence and the human experience behind every diagnosis.

Assoc. Prof. Priv.-Doz. Dr. Gerald Prager adalah seorang spesialis hematologi dan onkologi internal yang berbasis di Wina dengan pengalaman sekitar 17 hingga 19 tahun. Beliau lulus dari Universitas Kedokteran Wina. Dari tahun 2006 hingga 2011, beliau menyelesaikan residensi dan fellowship di bidang hematologi dan onkologi di sana. Pada tahun 2011, beliau menjadi Profesor Tamu di Norris Comprehensive Cancer Center (USC). Pada tahun 2012, beliau menjadi Associate Professor di MedUni Wina.

Beliau memimpin Precision Medicine in Cancer Unit. Karyanya berfokus pada kanker kolorektal, onkologi presisi, angiogenesis tumor, dan penilaian biomarker prediktif. Beliau adalah pengulas tetap untuk jurnal-jurnal terkemuka, termasuk Blood dan European Journal of Clinical Investigation.

Univ.-Prof. Dr. Heinz Gisslinger is a leading hematologist and internal oncologist at the Medical University of Vienna and the Confraternität Private Clinic Josefstadt. He helped found the Laboratory for Myeloproliferative Neoplasms. He is Program Director for Myeloproliferative Neoplasms and leads clinical and translational research.

He pioneered interferon therapy for myeloproliferative neoplasms (MPNs). He first used it clinically in the 1980s and has advanced it for more than four decades. His expertise includes polycythemia vera, essential thrombocythemia, primary myelofibrosis, chronic myeloid leukemia, and multiple myeloma.